SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
NVNO

enVVeno Medical Corp (NASDAQ:NVNO)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$5.25-$0.32 (-5.75%)
 
Market cap
$3.65M
Insider Score
Health Score
Listed since
May 31, 2018
Market Cap$3.65M-57.2%
Revenue (ttm)$0
Net Income-$15.55M+29.2%
EPS-$22.38+81.7%
Shares Out694.83K
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,355
Open$5.53
Previous Close$5.57
Day's Range$5.22 - $5.76
52-Week Range$5.22 - $14.89
Beta1.07
Analystsn/a
Price Targetn/a
Earnings DateMar 25, 2027
-3.59% (1D)
No price history available.

About NVNO

enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In addition to the VenoValve, enVVeno Medical is actively developing the enVVe system. This innovative system represents a non-surgical, transcatheter approach to venous valve replacement, comprising the enVVe valve itself, a dedicated delivery mechanism, and various supplementary accessories. The company previously operated under the name Hancock Jaffe Laboratories, Inc., before officially rebranding to enVVeno Medical Corporation in October 2021.

Address
70 Doppler, Irvine, CA, 92618, US
Market Cap
4 million
Employees
33
Industrial Classification
Medical - Devices

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$4.94K
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Fair
From NVNO’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-5.75%
5 Days
-14.08%
1 Month
-24.02%
6 Months
-52.10%
1 Year
-57.21%

$NVNO stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in NVNO holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by NVNO's directors and management

Net Shares Purchased by Insiders−5k−3k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

NVNO Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New NVNO patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to NVNO from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in NVNO

VXFVanguard Extended Market ETF$42.31K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from NVNO’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
0
Analyst Ratings
40% of score
60
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
4
Buy Value
$0
Distinct Buyers
0

Insider Score Trend Over Time

+0.0 since Sep 15
0255075100Sep 15 — Insider Score 0.0Sep 16 — Insider Score 0.0Sep 17 — Insider Score 0.0Sep 18 — Insider Score 0.0Sep 19 — Insider Score 0.0Sep 20 — Insider Score 0.0Sep 21 — Insider Score 0.0Sep 22 — Insider Score 0.0Sep 23 — Insider Score 0.0Sep 24 — Insider Score 0.0Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 54.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Sep 15Sep 24Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.